CD44 and breast carcinoma: Tanshinone IIA attenuated the stemness of breast cancer cells, evident by downregulating the expression of stemness markers, hindering the capacity of spheroid formation, decreasing the CD24−/CD44+ sub-population in a concentration-dependent manner and reducing the tumor-initiating ability of breast cancer cells.